Christoph Rischpler

10PUBLICATIONS
35CO-AUTHORS
Medical mycologyNanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)Te mātauranga reo Māori (Māori language education)Nuclear engineering (incl. fuel enrichment and waste processing and storage)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 21, 2023
Diagnostic significance of MRI versus CT using identical PET data in patients with recurrent differentiated thyroid cancer: A PET/MRI study.

Korbinian Westphal, Matthias Eiber, Martin Henninger

|Feb 13, 2023
Myocardial perfusion SPECT in Germany from 2012 to 2021: insights into development and quality indicators.

O Lindner, W Schäfer, C Rischpler

|Nov 05, 2022
Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM).

Matthias Totzeck, Nicolas Aide, Johann Bauersachs

|Jul 27, 2022
Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI-Clinically Relevant?

Kai Jannusch, Nils Martin Bruckmann, Charlotte Johanna Geuting

|Jul 14, 2022
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities.

Wolfgang P Fendler, Kim M Pabst, Lukas Kessler

|May 20, 2022
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study.

Manuel Weber, David Kersting, Burkhard Riemann

Pageof 2

Frequent Collaborators

2 joint publications

Manuel Weber

2 joint publications

Tienush Rassaf

2 joint publications

Lukas Kessler

1 joint publications

O Lindner